Immunocore (IMCR) News Today → CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (From Banyan Hill Publishing) (Ad) Free IMCR Stock Alerts $53.29 -0.96 (-1.77%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 8:38 PM | marketbeat.comImmunocore Holdings plc (NASDAQ:IMCR) Shares Sold by Nicholas Investment Partners LPNicholas Investment Partners LP decreased its position in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 89.8% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 52,159 shares of the company's stock after selling 460,696 shares during the period. NiMay 15 at 10:06 AM | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: OptimizeRx (OPRX), Immunocore Holdings (IMCR) and Acadia Healthcare (ACHC)May 15 at 4:01 AM | americanbankingnews.comImmunocore (NASDAQ:IMCR) Given New $88.00 Price Target at MizuhoMay 13, 2024 | marketbeat.comImmunocore (NASDAQ:IMCR) Sees Strong Trading VolumeImmunocore (NASDAQ:IMCR) Sees Strong Trading VolumeMay 13, 2024 | marketbeat.comImmunocore (NASDAQ:IMCR) PT Lowered to $88.00 at MizuhoMizuho decreased their target price on shares of Immunocore from $90.00 to $88.00 and set a "buy" rating on the stock in a research note on Monday.May 13, 2024 | americanbankingnews.comImmunocore (NASDAQ:IMCR) Given "Buy" Rating at Needham & Company LLCMay 13, 2024 | americanbankingnews.comCapital One Financial Comments on Immunocore Holdings plc's Q2 2024 Earnings (NASDAQ:IMCR)May 13, 2024 | americanbankingnews.comQ2 2024 EPS Estimates for Immunocore Holdings plc (NASDAQ:IMCR) Raised by HC WainwrightMay 13, 2024 | americanbankingnews.comImmunocore Holdings plc (NASDAQ:IMCR) to Post Q2 2024 Earnings of ($0.46) Per Share, Leerink Partnrs ForecastsMay 12, 2024 | marketbeat.comJump Financial LLC Purchases 16,345 Shares of Immunocore Holdings plc (NASDAQ:IMCR)Jump Financial LLC grew its holdings in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 57.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 44,900 shares of the company's stock after buying an additional 16,345 shares during the quarter.May 11, 2024 | finance.yahoo.comAnalysts Have Made A Financial Statement On Immunocore Holdings plc's (NASDAQ:IMCR) First-Quarter ReportMay 10, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Immunocore Holdings (IMCR), Warby Parker (WRBY) and Ocular Therapeutix (OCUL)May 10, 2024 | markets.businessinsider.comBuy Rating Affirmed for Immunocore Holdings on Strong KIMMTRAK Sales and Promising Pipeline GrowthMay 10, 2024 | markets.businessinsider.comOppenheimer Reaffirms Their Buy Rating on Immunocore Holdings (IMCR)May 9, 2024 | marketbeat.comImmunocore (NASDAQ:IMCR) PT Raised to $100.00HC Wainwright increased their price objective on Immunocore from $90.00 to $100.00 and gave the stock a "buy" rating in a research report on Thursday.May 9, 2024 | marketbeat.comImmunocore (NASDAQ:IMCR) Issues Quarterly Earnings ResultsImmunocore (NASDAQ:IMCR - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.49) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.37) by ($0.12). Immunocore had a negative return on equity of 15.78% and a negative net margin of 22.48%. The company had revenue of $70.30 million for the quarter, compared to analyst estimates of $70.72 million. During the same period last year, the firm earned ($0.35) earnings per share. The firm's revenue for the quarter was up 27.6% on a year-over-year basis.May 9, 2024 | marketbeat.comImmunocore (NASDAQ:IMCR) Stock Rating Reaffirmed by Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and set a $81.00 price target on shares of Immunocore in a research note on Thursday.May 9, 2024 | markets.businessinsider.comImmunocore Holdings Outperforms with Kimmtrak Sales Surpassing Estimates; Maintains Buy RatingMay 9, 2024 | markets.businessinsider.comBuy Rating for Immunocore Holdings on Strong Financials and Expanding Innovative PipelineMay 8, 2024 | finance.yahoo.comImmunocore Holdings PLC Reports Q1 2024 Earnings: Misses EPS Estimates, Surpasses Revenue ForecastsMay 8, 2024 | investorplace.comIMCR Stock Earnings: Immunocore Hldgs Misses EPS, Misses Revenue for Q1 2024May 8, 2024 | finanznachrichten.deImmunocore Holdings plc: Immunocore reports first quarter financial results and provides a business updateMay 8, 2024 | globenewswire.comImmunocore reports first quarter financial results and provides a business updateMay 2, 2024 | marketbeat.comImmunocore Holdings plc (NASDAQ:IMCR) Expected to Earn Q1 2024 Earnings of ($0.49) Per ShareImmunocore Holdings plc (NASDAQ:IMCR - Free Report) - Equities research analysts at Leerink Partnrs issued their Q1 2024 earnings per share estimates for shares of Immunocore in a research report issued on Monday, April 29th. Leerink Partnrs analyst J. Chang anticipates that the company will earnMay 2, 2024 | marketbeat.comImmunocore (NASDAQ:IMCR) Given "Outperform" Rating at Leerink PartnrsLeerink Partnrs restated an "outperform" rating on shares of Immunocore in a report on Monday.April 30, 2024 | msn.comLeerink Partners Initiates Coverage of Immunocore Holdings plc - Depositary Receipt () (IMCR) with Outperform RecommendationApril 29, 2024 | marketbeat.comImmunocore (NASDAQ:IMCR) Research Coverage Started at SVB LeerinkSVB Leerink began coverage on shares of Immunocore in a research note on Monday. They issued an "outperform" rating and a $74.00 price objective for the company.April 29, 2024 | marketbeat.comNew York State Common Retirement Fund Boosts Holdings in Immunocore Holdings plc (NASDAQ:IMCR)New York State Common Retirement Fund boosted its position in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 23.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 244,439 shares of the companApril 27, 2024 | marketbeat.comImmunocore Holdings plc (NASDAQ:IMCR) Shares Sold by Cwm LLCCwm LLC lessened its stake in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 54.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 24,225 shares of the company's stock after selling 29,176 shares during the period. Cwm LLC's holdings in Immunocore were wApril 26, 2024 | finanznachrichten.deImmunocore Holdings plc: Immunocore announces upcoming presentation and posters at ASCO 2024April 24, 2024 | globenewswire.comImmunocore announces upcoming presentation and posters at ASCO 2024April 23, 2024 | marketbeat.comImmunocore's (IMCR) Buy Rating Reaffirmed at GuggenheimGuggenheim reissued a "buy" rating and set a $92.00 target price on shares of Immunocore in a research note on Tuesday.April 23, 2024 | marketbeat.comMutual of America Capital Management LLC Takes $940,000 Position in Immunocore Holdings plc (NASDAQ:IMCR)Mutual of America Capital Management LLC acquired a new stake in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 13,754 shares of the company's stock, valued at approximateApril 19, 2024 | marketbeat.comImmunocore Holdings plc (NASDAQ:IMCR) Stock Holdings Lessened by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC reduced its holdings in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 21.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 85,784 shares of the company's stock after selling 22,867 sharesApril 11, 2024 | markets.businessinsider.comImmunocore Hldgs Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)April 11, 2024 | marketbeat.comImmunocore's (IMCR) "Buy" Rating Reiterated at Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and issued a $81.00 price objective on shares of Immunocore in a report on Thursday.April 10, 2024 | nasdaq.comValidea Detailed Fundamental Analysis - IMCRApril 9, 2024 | marketbeat.comImmunocore (NASDAQ:IMCR) Shares Down 4.2% Immunocore (NASDAQ:IMCR) Stock Price Down 4.2%April 5, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Catalent (CTLT), Alvotech (ALVO) and Immunocore Holdings (IMCR)April 5, 2024 | investing.comImmunocore executive sells shares worth over $280,000April 4, 2024 | globenewswire.comImmunocore to present at upcoming investor conferencesMarch 22, 2024 | marketbeat.comImmunocore (NASDAQ:IMCR) Trading 3% Higher Immunocore (NASDAQ:IMCR) Stock Price Up 3%March 21, 2024 | marketbeat.comImmunocore (NASDAQ:IMCR) Price Target Increased to $70.00 by Analysts at JPMorgan Chase & Co.JPMorgan Chase & Co. boosted their price target on shares of Immunocore from $60.00 to $70.00 and gave the stock an "overweight" rating in a research report on Wednesday.March 18, 2024 | marketbeat.comImmunocore Holdings plc (NASDAQ:IMCR) Short Interest UpdateImmunocore Holdings plc (NASDAQ:IMCR - Get Free Report) saw a significant increase in short interest in February. As of February 29th, there was short interest totalling 4,230,000 shares, an increase of 9.6% from the February 14th total of 3,860,000 shares. Approximately 8.7% of the shares of the stock are sold short. Based on an average daily volume of 494,300 shares, the days-to-cover ratio is currently 8.6 days.March 16, 2024 | marketbeat.comWellington Management Group LLP Purchases 217,920 Shares of Immunocore Holdings plc (NASDAQ:IMCR)Wellington Management Group LLP boosted its position in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 5.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,913,410 shares of the comMarch 16, 2024 | finance.yahoo.comIMCR Apr 2024 45.000 putMarch 16, 2024 | finance.yahoo.comIMCR Apr 2024 95.000 callMarch 12, 2024 | marketbeat.comPolar Capital Holdings Plc Buys 207,664 Shares of Immunocore Holdings plc (NASDAQ:IMCR)Polar Capital Holdings Plc increased its stake in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 490.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 250,000 shares of the company's stock after purcMarch 11, 2024 | markets.businessinsider.comCastle Biosciences: A Strong Buy on Genomic Diagnostic Leadership and Market Growth PotentialMarch 11, 2024 | marketbeat.comImmunocore Holdings plc (NASDAQ:IMCR) Given Consensus Rating of "Moderate Buy" by AnalystsShares of Immunocore Holdings plc (NASDAQ:IMCR - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the fourteen ratings firms that are presently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and twelve have gi Get Immunocore News Delivered to You Automatically Sign up to receive the latest news and ratings for IMCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Dems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election. See who it is HERE. IMCR Media Mentions By Week IMCR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMCR News Sentiment▼0.120.49▲Average Medical News Sentiment IMCR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMCR Articles This Week▼203▲IMCR Articles Average Week Get Immunocore News Delivered to You Automatically Sign up to receive the latest news and ratings for IMCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TWST News Today DNLI News Today ACLX News Today IOVA News Today SWTX News Today VCEL News Today RXRX News Today APGE News Today KYMR News Today ADMA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMCR) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaBreaking News: Elon Musk Invents New Type of A.I. (Shocking)InvestorPlaceI’m afraid WWIII is a very real possibility Porter & CompanyProtect Your Bank Account Before It’s Too LateWeiss RatingsUrgent Nvidia WarningAltimetryExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunocore Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
